Anticorps Polyclonaux Biotinylés

Biotinylated Anti-Human TACI

0 ReviewsSubmit a Review

Product Details

Catalogue Number: 500-P166GBT

Source: Polyclonal Goat

Preparation: Produced from sera of goats pre-immunized with highly pure (>98%) recombinant hTACI. Anti-Human TACI specific antibody was purified by affinity chromatography and then biotinylated.

Immunogen: E.coli-derived, 17.8 kDa Recombinant Human TACI (PeproTech catalog# 310-17)

Sandwich ELISA: To detect hTACI by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.25 – 1.0 μg/ml of this antibody is required. This biotinylated polyclonal antibody, in conjunction with PeproTech’s Polyclonal Anti-Human TACI (500-P166G) as a capture antibody, allows the detection of at least 0.2 – 0.4 ng/well of recombinant hTACI.

Biotinylated Anti-Human TACI Sandwich ELISA

Western Blot: To detect hTACI by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hTACI is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.

Biotinylated Anti-Human TACI Western Blot Reduced Biotinylated Anti-Human TACI Western Blot Unreduced


1mg will be provided as 2x500μg.

Country Of Origin: USA

Not for human use.

Research Interest


First Author
Salzer, U
Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes.
Blood; 113(9) pg1967-76
PubMed Id
First Author
Lee, J J
The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function.
Blood; 114(11) pg2254-62
PubMed Id
First Author
Cuss, A K
Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity.
Journal of immunology (Baltimore, Md. : 1950); 176(3) pg1506-16
PubMed Id